Showing results (371-380 of 3,164) with videos related to
Sort By:
Pageof 317
Translational Oncology|January 19, 2024
m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferationYuan Gao, Miao Yu, Zengyuan Liu, et al.Translational Oncology|December 22, 2023
LGR5, a prognostic stem cell target, promotes endometrial cancer proliferation through autophagy activationChengcheng Li, Xiao Yang, Yuan Cheng, et al.Translational Oncology|December 15, 2023
Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinomaWei Sun, Pengpeng Zhang, Bicheng Ye, et al.Translational Oncology|March 31, 2024
Expression of KCNN4 in adult-type diffuse gliomas and its correlations with clinicopathological features and patient prognosisJun Yang, Zhuonan Pu, Xiaorong Tao, et al.Translational Oncology|March 31, 2024
Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBCYunfei Wu, Zhijie Xu, Guanghou Fu, et al.Translational Oncology|March 17, 2024
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancerFang Wang, Dingtao Hu, Xiaoqi Lou, et al.Translational Oncology|March 16, 2024
Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancerTianzhe Jin, Taotao Yin, Ruiyi Xu, et al.Translational Oncology|March 3, 2024
Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancerZinan Lu, Peiwen Fan, Wen Huo, et al.Translational Oncology|February 28, 2024
Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironmentYucheng Dong, Zhizhuo Chen, Fan Yang, et al.Translational Oncology|February 27, 2024
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with BirinapantChristophe Van Berckelaer, Steven Van Laere, Seayoung Lee, et al.Pageof 317